Medroxyprogesterone acetate (MPA)

Diseases for which it is used

• Endometrial cancer

Diseases for which it was used

• Breast cancer
• Renal cell carcinoma

History of changes in FDA indication

• 1959-06-18: Initial approval

History of changes in EMA indication

• 1959-08-20: EURD

Also known as

• Generic names: medroxyprogesterone acetate, MPA
• Brand names: Depo-Provera, Provera